Brandt M, Hofmann K D, Koob P
Zentralbl Gynakol. 1980;102(6):353-6.
Plasma activities of the fibrin-stabilising factor (Factor XIII) were tested in 60 women who were on hormonal contraceptives, different in composition (Non Ovlon and Gravistat). The activities in either group were reduced with significance, notwithstanding steroid levels. Unambiguous interpretation of that reduction proved impossible.
对60名服用成分不同(诺炔酮和炔诺孕酮)的激素避孕药的女性进行了纤维蛋白稳定因子(因子 XIII)的血浆活性测试。尽管类固醇水平不同,但两组的活性均显著降低。事实证明,无法对这种降低作出明确的解释。